- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Jones Lang LaSalle Releases Emerging Life Sciences Markets Index
Next tier of markets is poised to ascend and offer valuable opportunities to both investors and occupiers.
JLL, a global commercial real estate services company, has released its Emerging Life Sciences Markets Index. The report evaluates metro areas with respect to a wide variety of metrics chosen to best reflect the most critical qualities of life sciences markets on the upswing.
Examining 110 US markets, the index highlights where life sciences jobs are growing the most as well as what markets are accelerating and keeping a full pipeline of talent. The result of this research is a three-pronged model:
- Momentum: measures the size of the life sciences employment base and the industry’s momentum
- Talent: measures educational attainment and demographic tailwinds
- Potential: measures forecasted growth of key market performance indicators such as millennial population, median household income growth, and housing availability
For more information and the full report, click here.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
